RxDoctor Payments Data

Jenny Rhee, NP

Adult Health · Falls Church, VANPI 1538798962

Payments from drug & device makers

$1,991in general payments, 2019–2025

Across 97 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$297
  • Pfizer$245
  • AstraZeneca$194
  • Novartis$176
  • Boehringer Ingelheim$169
  • Alnylam Pharmaceuticals Inc.$168
  • plus $742 from 17 others

What the payments were for

  • Food & beverage$1,991100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,991 in reported general payments places this provider in the 75th percentile of 368 adult health providers in Virginia.

See all adult health providers in Virginia

Medicare billing

Part B allowed, 2024
$1,347
Medicare patients
12
Services billed
19

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyndamaxTafamidis56$1,416,238
VyndaqelTafamidis Meglumine16$330,402
EntrestoSacubitril/Valsartan134$202,935
JardianceEmpagliflozin128$177,258
EliquisApixaban109$141,211
FarxigaDapagliflozin Propanediol47$50,798
BrilintaTicagrelor27$19,424
XareltoRivaroxaban13$15,766
DapagliflozinDapagliflozin Propanediol11$5,650
Eplerenone38$3,217
Metoprolol Succinate188$3,029
Torsemide82$2,428
Valsartan88$2,090
Spironolactone225$1,725
Bumetanide47$1,604

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerVyndamax, Vyndaqel, Eliquis$245$1,887,851181 claims
NovartisEntresto$176$202,935134 claims
Boehringer IngelheimJardiance$169$177,258128 claims
AstraZenecaFarxiga, Brilinta$194$70,22274 claims
Johnson & JohnsonXarelto$89$15,76613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 368 adult health providers in Virginia.

Other adult health in Falls Church

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →